Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Mortality and Morbidity Following Prostate Biopsy

Principal Investigator
Name
Paul Pinsky
Institution
NCI, DCP, EDRG
Position Title
Researcher
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-12
Initial CDAS Request Approval
Jan 17, 2013
Title
Mortality and Morbidity Following Prostate Biopsy
Summary
We will examine mortality and complications following prostate biopsy in PLCO. For mortality, the death rate following prostate biopsy will be compared to that of an appropriate internal control group without biopsy.
Aims

1. To examine the mortality rate following prostate biopsy and compare to that of an appropriate internal control group. A model will be developed to control for possible confounders.

2. To examine complications following prostate biopsy.

Collaborators

Howard Parnes, NCI